Posted by Michael Wonder on 18 May 2020
The coronavirus exposed the US' reliance on India for generic drugs. But that supply chain is ultimately controlled by China
17 May 2020 - Sarah Thebarge, a 41-year-old physician assistant living in San Francisco, takes a pill every day to treat her lupus, a chronic condition that causes unbearable joint pain, fatigue and fainting spells.
The medicine she takes is hydroxychloroquine.
But in March, hydroxychloroquine, which is also used to treat malaria, suddenly became harder to get after US President Donald Trump touted the drug as a possible treatment for COVID-19.
